ENALAPRIL WORLDWIDE EXPERIENCE

被引：130

作者：

DAVIES, RO ^{[1
]}

IRVIN, JD ^{[1
]}

KRAMSCH, DK ^{[1
]}

WALKER, JF ^{[1
]}

MONCLOA, F ^{[1
]}

机构：

[1] MERCK SHARP & DOHME RES LABS, W POINT, PA 19486 USA

来源：

AMERICAN JOURNAL OF MEDICINE | 1984年 / 77卷 / 2A期

关键词：

D O I：

10.1016/S0002-9343(84)80055-8

中图分类号：

R5 [内科学];

学科分类号：

1002 [临床医学]; 100201 [内科学];

摘要：

引用

收藏

页码：23 / 35

页数：13

相关论文

共 22 条

[1]

BERGSTRAND R, 1982, BRIT J CLIN PHARMACO, V14, pP136

[2]

ANTIHYPERTENSIVE THERAPY WITH MK-421 - ANGIOTENSIN-II-RENIN RELATIONSHIPS TO EVALUATE EFFICACY OF CONVERTING ENZYME BLOCKADE [J].

BIOLLAZ, J ;

BRUNNER, HR ;

GAVRAS, I ;

WAEBER, B ;

GAVRAS, H .

JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1982, 4 (06) :966-972

[3]

3 NEW LONG-ACTING CONVERTING-ENZYME INHIBITORS - RELATIONSHIP BETWEEN PLASMA CONVERTING-ENZYME ACTIVITY AND RESPONSE TO ANGIOTENSIN-I [J].

BIOLLAZ, J ;

BURNIER, M ;

TURINI, GA ;

BRUNNER, DB ;

PORCHET, M ;

GOMEZ, HJ ;

JONES, KH ;

FERBER, F ;

ABRAMS, WB ;

GAVRAS, H ;

BRUNNER, HR .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1981, 29 (05) :665-670

[4]

EFFECT OF A NEW ANGIOTENSIN CONVERTING ENZYME-INHIBITOR MK 421 AND ITS LYSINE ANALOG ON THE COMPONENTS OF THE RENIN SYSTEM IN HEALTHY-SUBJECTS [J].

BRUNNER, DB ;

DESPONDS, G ;

BIOLLAZ, J ;

KELLER, I ;

FERBER, F ;

GAVRAS, H ;

BRUNNER, HR ;

SCHELLING, JL .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1981, 11 (05) :461-467

[5]

CRESSMAN MD, 1982, LANCET, V2, P440

[6]

EFFECTS OF ENALAPRIL, A NEW CONVERTING ENZYME-INHIBITOR, IN HYPERTENSION [J].

FERGUSON, RK ;

VLASSES, PH ;

SWANSON, BN ;

MOJAVERIAN, P ;

HICHENS, M ;

IRVIN, JD ;

HUBER, PB .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1982, 32 (01) :48-53

[7]

FERGUSON RK, 1983, CLIN PHARMACOL THER, V33, P254

[8]

GAVRAS H, 1981, LANCET, V2, P543

[9]

ALTERED FRACTIONAL TETRAHYDROALDOSTERONE EXCRETION DURING PHARMACOLOGICAL BLOCKADE AND ACTIVATION OF THE RENIN-ALDOSTERONE SYSTEM [J].

GRIFFING, GT ;

WILSON, TE ;

MELBY, JC .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1982, 55 (06) :1217-1221

[10]

REVERSAL OF DIURETIC-INDUCED SECONDARY HYPER-ALDOSTERONISM AND HYPOKALEMIA BY ENALAPRIL (MK-421) - A NEW ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR [J].

GRIFFING, GT ;

SINDLER, BH ;

AURECCHIA, SA ;

MELBY, JC .

METABOLISM-CLINICAL AND EXPERIMENTAL, 1983, 32 (07) :711-716